Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Fear S"'
Autor:
Wuerstlein, R., Ellis, P., Montemurro, F., Antón Torres, A., Delaloge, S., Zhang, Q., Wang, X., Wang, S., Shao, Z., Li, H., Rachman, A., Vongsaisuwon, M., Liu, H., Fear, S., Peña-Murillo, C., Barrios, C.
Publikováno v:
In ESMO Open October 2022 7(5)
Autor:
Tabernero, J., Andre, F., Blay, J.-Y., Bustillos, A., Fear, S., Ganta, S., Jaeger, D., Maio, M., Mileshkin, L., Melero, I.
Publikováno v:
In ESMO Open April 2022 7(2)
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Mego, M., Huddart, R. A., Voortman, J., Ong, M., Gedye, C., Gurney, H., Fay, A. P., Bamias, A., Mellado Gonzalez, B., Loriot, Y., Merseburger, A. S., Castellano Gauna, D., de Ducla, S., Pavlova, J., Fear, S., Sternberg, C. N.
Publikováno v:
Annals of Oncology, 31, S591-S591. Oxford University Press
Mego, M, Huddart, R A, Voortman, J, Ong, M, Gedye, C, Gurney, H, Fay, A P, Bamias, A, Mellado Gonzalez, B, Loriot, Y, Merseburger, A S, Castellano Gauna, D, de Ducla, S, Pavlova, J, Fear, S & Sternberg, C N 2020, ' Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study ', Annals of Oncology, vol. 31, pp. S591-S591 . https://doi.org/10.1016/j.annonc.2020.08.838
Mego, M, Huddart, R A, Voortman, J, Ong, M, Gedye, C, Gurney, H, Fay, A P, Bamias, A, Mellado Gonzalez, B, Loriot, Y, Merseburger, A S, Castellano Gauna, D, de Ducla, S, Pavlova, J, Fear, S & Sternberg, C N 2020, ' Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study ', Annals of Oncology, vol. 31, pp. S591-S591 . https://doi.org/10.1016/j.annonc.2020.08.838
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::24d6545c8ec7c5acc66ba6e2ec8909b4
https://research.vumc.nl/en/publications/87c55a6e-4faf-48ed-aea2-27cb08420fe9
https://research.vumc.nl/en/publications/87c55a6e-4faf-48ed-aea2-27cb08420fe9
Background: Atezolizumab, a humanised monoclonal antibody targeting PD-L1, is approved for locally advanced/metastatic urothelial carcinoma. SAUL evaluated atezolizumab in a broader, pretreated population, including patients ineligible for the pivota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::38a5c318e70aba4237a50a6f72e251a8
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3105899
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3105899
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S1027-S1028
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hedayati, B, Fear, S
Publikováno v:
In British Journal of Anaesthesia November 1999 83(5):776-779
Autor:
Mego, M., Huddart, R.A., Voortman, J., Ong, M., Gedye, C., Gurney, H., Fay, A.P., Bamias, A., Mellado Gonzalez, B., Loriot, Y., Merseburger, A.S., Castellano Gauna, D., de Ducla, S., Pavlova, J., Fear, S., Sternberg, C.N.
Publikováno v:
In Annals of Oncology September 2020 31 Supplement 4:S591-S591